Manuyakorn W et al. |
In vitro cytokine changes after pediatric liver transplantation. |
2015 |
Asian Pac. J. Allergy Immunol. |
pmid:25840634
|
Li T et al. |
Effect of FK506 nanospheres on regeneration of allogeneic nerve after transplant. |
2014 |
Asian Pac J Trop Med |
pmid:25066398
|
Dai YJ et al. |
Effect of pharmacological intervention on MIP-1α, MIP-1β and MCP-1 expression in patients with psoriasis vulgaris. |
2014 |
Asian Pac J Trop Med |
pmid:25063291
|
Ogita K et al. |
Renal tubular acidosis secondary to FK506 in living donor liver transplantation: a case report. |
2003 |
Asian J Surg |
pmid:14530108
|
Cacciarelli TV et al. |
Influence of the timing of FK 506 (Tacrolimus) administration on recovery of renal function from warm ischemic injury in rats. |
1994 Oct-Dec |
ASAIO J. |
pmid:7532042
|
Tsubo T et al. |
Elimination of FK-506 by continuous hemodiafiltration in a liver transplant patient. |
1997 Jul-Aug |
ASAIO J. |
pmid:9242954
|
Imanishi Y et al. |
Pharmacokinetic properties of a once-daily formulation of tacrolimus in patients with renal transplantation. |
2011 |
Arzneimittelforschung |
pmid:21528645
|
Takayama T et al. |
Effects of the novel and potent lymphocyte-specific protein tyrosine kinase inhibitor TKM0150 on mixed lymphocyte reaction and contact hypersensitivity in mice. |
2010 |
Arzneimittelforschung |
pmid:20533766
|
Lainesse A et al. |
Bioequivalence studies of tacrolimus capsule under fasting and fed conditions in healthy male and female subjects. |
2008 |
Arzneimittelforschung |
pmid:18589558
|
Haehner T et al. |
Drug-drug interactions evaluated by a highly active reconstituted native human cytochrome P4503A4 and human NADPH-cytochrome P450 reductase system. |
2004 |
Arzneimittelforschung |
pmid:14979613
|
MarcelÃn-Jiménez G et al. |
Development of an ultra-performance liquid chromatography technique coupled with mass spectrometry for the measurement of tacrolimus in micro-samples of whole blood, and its application on a pharmacokiinetic trial. |
2007 |
Arzneimittelforschung |
pmid:18074760
|
Iwasaki K et al. |
Effect of repeated oral doses of a novel immunosuppressive macrolide lactone on hepatic mixed-function oxidase system in the rat. Comparative study with ciclosporin. |
1992 |
Arzneimittelforschung |
pmid:1379812
|
Dawson S et al. |
UCLA liver transplantation: analysis of immunological factors affecting outcome. |
1996 |
Artif Organs |
pmid:8896726
|
Kashu Y et al. |
Prolongation of rat liver graft survival by splenectomy combined with low dose FK506 therapy. |
1996 |
Artif Organs |
pmid:8896731
|
Ohshima S et al. |
Immunosuppressive treatment of primary cadaveric renal transplant patients receiving kidneys from non-heart beating donors. |
1996 |
Artif Organs |
pmid:8896734
|
Wada Y et al. |
BCX-34: a novel T-cell selective immunosuppressant: purine nucleoside phosphorylase (PNP) inhibitor. |
1996 |
Artif Organs |
pmid:8853794
|
Haisheng H et al. |
Assessment of nerve regeneration across nerve allografts treated with tacrolimus. |
2008 |
Artif Cells Blood Substit Immobil Biotechnol |
pmid:18925465
|
van der Windt AE et al. |
Inhibiting calcineurin activity under physiologic tonicity elevates anabolic but suppresses catabolic chondrocyte markers. |
2012 |
Arthritis Rheum. |
pmid:22231955
|
Suzuki N et al. |
In vivo mechanisms for the inhibition of T lymphocyte activation by long-term therapy with tacrolimus (FK-506): experience in patients with Behçet's disease. |
1997 |
Arthritis Rheum. |
pmid:9182928
|
de Paulis A et al. |
Human synovial mast cells. II. Heterogeneity of the pharmacologic effects of antiinflammatory and immunosuppressive drugs. |
1997 |
Arthritis Rheum. |
pmid:9082935
|
Cho ML et al. |
Cyclosporine differentially regulates interleukin-10, interleukin-15, and tumor necrosis factor a production by rheumatoid synoviocytes. |
2002 |
Arthritis Rheum. |
pmid:11817607
|
Kremer JM et al. |
Tacrolimus in rheumatoid arthritis patients receiving concomitant methotrexate: a six-month, open-label study. |
2003 |
Arthritis Rheum. |
pmid:14558080
|
Asano Y et al. |
Differential effects of the immunosuppressant FK-506 on human alpha2(I) collagen gene expression and transforming growth factor beta signaling in normal and scleroderma fibroblasts. |
2005 |
Arthritis Rheum. |
pmid:15818662
|
Wilkes MR et al. |
Treatment of antisynthetase-associated interstitial lung disease with tacrolimus. |
2005 |
Arthritis Rheum. |
pmid:16052580
|
Stone JH et al. |
Outcome of renal transplantation in ninety-seven cyclosporine-era patients with systemic lupus erythematosus and matched controls. |
1998 |
Arthritis Rheum. |
pmid:9704643
|
Yocum DE et al. |
Efficacy and safety of tacrolimus in patients with rheumatoid arthritis: a double-blind trial. |
2003 |
Arthritis Rheum. |
pmid:14673984
|
Furst DE et al. |
Efficacy of tacrolimus in rheumatoid arthritis patients who have been treated unsuccessfully with methotrexate: a six-month, double-blind, randomized, dose-ranging study. |
2002 |
Arthritis Rheum. |
pmid:12209503
|
Cho ML et al. |
Cyclosporine inhibition of vascular endothelial growth factor production in rheumatoid synovial fibroblasts. |
2002 |
Arthritis Rheum. |
pmid:12115224
|
Parker CT and Rennie T |
Failure to report previously used drugs and dosages in pharmaceutical company-sponsored rheumatoid arthritis trials: comment on the article by Yocum et al. |
2004 |
Arthritis Rheum. |
pmid:15457479
|
Migita K et al. |
Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tacrolimus. |
2015 |
Arthritis Res. Ther. |
pmid:26036592
|
Choe JY et al. |
Regulatory effect of calcineurin inhibitor, tacrolimus, on IL-6/sIL-6R-mediated RANKL expression through JAK2-STAT3-SOCS3 signaling pathway in fibroblast-like synoviocytes. |
2013 |
Arthritis Res. Ther. |
pmid:23406906
|
Long C et al. |
Removal of FKBP12/12.6 from endothelial ryanodine receptors leads to an intracellular calcium leak and endothelial dysfunction. |
2007 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:17478757
|
Ikezoe T et al. |
Thrombomodulin protects endothelial cells from a calcineurin inhibitor-induced cytotoxicity by upregulation of extracellular signal-regulated kinase/myeloid leukemia cell-1 signaling. |
2012 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:22796578
|
Murakami R et al. |
Cyclosporin A enhances interleukin-8 expression by inducing activator protein-1 in human aortic smooth muscle cells. |
2003 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:12958044
|
Vindis C et al. |
Two distinct calcium-dependent mitochondrial pathways are involved in oxidized LDL-induced apoptosis. |
2005 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:15618541
|
Lasa J and Olivera P |
EFFICACY OF TACROLIMUS FOR INDUCTION OF REMISSION IN PATIENTS WITH MODERATE-TO-SEVERE ULCERATIVE COLITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS. |
|
Arq Gastroenterol |
pmid:28327826
|
Müller EG et al. |
Tacrolimus eye drops as monotherapy for vernal keratoconjunctivitis: a randomized controlled trial. |
2017 |
Arq Bras Oftalmol |
pmid:28832739
|
Liendo VL et al. |
Topical tacrolimus for the treatment of severe allergic keratoconjunctivitis in children. |
|
Arq Bras Oftalmol |
pmid:28954018
|
Zulim LFDC et al. |
Comparison of the efficacy of 0.03% tacrolimus eye drops diluted in olive oil and linseed oil for the treatment of keratoconjunctivitis sicca in dogs. |
|
Arq Bras Oftalmol |
pmid:29995121
|
Carvalho CS et al. |
[Fibroblasts from recurrent pterygium and normal Tenon's capsule exposed to tacrolimus (FK-506)]. |
2007 Mar-Apr |
Arq Bras Oftalmol |
pmid:17589693
|
Nakamura K |
[Treatment of atopic dermatitis]. |
2009 |
Arerugi |
pmid:19901507
|
Saeki H |
[Brief commentary on guidelines for the management of atopic dermatitis 2012 -the point of drug treatment]. |
2013 |
Arerugi |
pmid:24608647
|
Ochiai T |
[Advances in the fundamentals and therapeutic use of immunosuppressive agents]. |
1992 |
Arerugi |
pmid:1374229
|
Teraki Y |
[Atopic dermatitis in pregnancy]. |
2014 |
Arerugi |
pmid:24714179
|
Ebihara N |
[New strategy in the treatment of vernal keratoconjunctivitis by calcineurin inhibitor eye drops]. |
2010 |
Arerugi |
pmid:21119297
|
Akutsu I et al. |
[Inhibitory effects of cyclosporin A and FK-506 on eosinophil chemotactic factor activity in culture supernatants of mononuclear cells from asthmatics]. |
1992 |
Arerugi |
pmid:1280086
|
Yamamoto S |
[Guidelines for the management of atopic dermatitis 2006]. |
2008 |
Arerugi |
pmid:19052504
|
Akutsu I et al. |
[Inhibitory effect of inhaled FK-506 on increased bronchial responsiveness and eosinophil infiltration in the airway mucosa]. |
1992 |
Arerugi |
pmid:1377905
|
Hossain M et al. |
Effects of various drugs (staurosporine, herbimycin A, ketotifen, theophylline, FK506 and cyclosporin A) on eosinophil viability. |
1994 |
Arerugi |
pmid:7520689
|
Takehara K |
[Treatment of juvenile atopic dermatitis]. |
2010 |
Arerugi |
pmid:21212728
|
Akutsu I et al. |
[Inhibitory effect of FK-506 on the development of late asthmatic response and on the increased bronchial responsiveness]. |
1990 |
Arerugi |
pmid:1705791
|
Ohtsuki M |
[Tacrolimus ointment for the treatment of atopic dermatitis]. |
2009 |
Arerugi |
pmid:19487830
|
Nishimoto K et al. |
[Case of organizing pneumonia associated with sweet's syndrome]. |
2014 |
Arerugi |
pmid:25163580
|
Briggs CJ et al. |
Comparison of the effect of FK506 and cyclosporin A on virus production in H9 cells chronically and newly infected by HIV-1. |
1999 |
Arch. Virol. |
pmid:10603169
|
Minder D et al. |
Immunophilins and HIV-1 infection. |
2002 |
Arch. Virol. |
pmid:12181673
|
Ellouk-Achard S et al. |
Implication of CYP 3A in the toxicity of cyclosporin G (CsG), cyclosporin A (CsA) and FK506 on rat hepatocytes in primary culture. |
1997 |
Arch. Toxicol. |
pmid:9209689
|
Aam BB and Fonnum F |
Carbon black particles increase reactive oxygen species formation in rat alveolar macrophages in vitro. |
2007 |
Arch. Toxicol. |
pmid:17119925
|
Kafert-Kasting S et al. |
Safety assessment of intraportal liver cell application in New Zealand white rabbits under GLP conditions. |
2012 |
Arch. Toxicol. |
pmid:22532025
|
Massicot F et al. |
Modulation of energy status and cytotoxicity induced by FK506 and cyclosporin A in a renal epithelial cell line. |
1997 |
Arch. Toxicol. |
pmid:9248632
|
Kimura Y et al. |
Profiling the immunotoxicity of chemicals based on in vitro evaluation by a combination of the Multi-ImmunoTox assay and the IL-8 Luc assay. |
2018 |
Arch. Toxicol. |
pmid:29594315
|
Vandenbussche C et al. |
Tacrolimus-induced nephrotoxicity in mice is associated with microRNA deregulation. |
2018 |
Arch. Toxicol. |
pmid:29362864
|
Ellouk-Achard S et al. |
FK506 (Tacrolimus) decreases the cytotoxicity of cyclosporin A in rat hepatocytes in primary culture: implication of CYP3A induction. |
1998 |
Arch. Toxicol. |
pmid:9630010
|
Schaap MM et al. |
A novel toxicogenomics-based approach to categorize (non-)genotoxic carcinogens. |
2015 |
Arch. Toxicol. |
pmid:25270620
|
Chung Y and Cho H |
Preparation of highly water soluble tacrolimus derivatives: poly(ethylene glycol) esters as potential prodrugs. |
2004 |
Arch. Pharm. Res. |
pmid:15460452
|
Kwon M et al. |
Bioequivalence of tacrolimus formulations with different dynamic solubility and in-vitro dissolution profiles. |
2015 |
Arch. Pharm. Res. |
pmid:24627339
|
Park YJ et al. |
Physicochemical characterization of tacrolimus-loaded solid dispersion with sodium carboxylmethyl cellulose and sodium lauryl sulfate. |
2009 |
Arch. Pharm. Res. |
pmid:19557367
|
Seo YG et al. |
Preparation and pharmaceutical evaluation of new tacrolimus-loaded solid self-emulsifying drug delivery system. |
2015 |
Arch. Pharm. Res. |
pmid:25134927
|
Park JS et al. |
A rapid and sensitive method to determine tacrolimus in rat whole blood using liquid-liquid extraction with mild temperature ultrasonication and LC-MS/MS. |
2016 |
Arch. Pharm. Res. |
pmid:26589688
|
Choi D and Cho H |
Effect of tacrolimus derivatives on immunosuppression. |
2009 |
Arch. Pharm. Res. |
pmid:19407973
|
Choi D et al. |
Effects of water-soluble tacrolimus-PEG conjugate on insulin-dependent diabetes mellitus and systemic lupus erythematosus. |
2011 |
Arch. Pharm. Res. |
pmid:21910052
|
Hüser N et al. |
Graft preconditioning with low-dose tacrolimus (FK506) and nitric oxide inhibitor aminoguanidine (AGH) reduces ischemia/reperfusion injury after liver transplantation in the rat. |
2009 |
Arch. Pharm. Res. |
pmid:19280151
|
Etzell JE and Wang E |
Acquired Pelger-Huët anomaly in association with concomitant tacrolimus and mycophenolate mofetil in a liver transplant patient: a case report and review of the literature. |
2006 |
Arch. Pathol. Lab. Med. |
pmid:16390246
|
DiGiuseppe JA et al. |
Tacrolimus-related posttransplant lymphoproliferative disorder presenting as autoimmune hemolytic anemia. |
1996 |
Arch. Pathol. Lab. Med. |
pmid:8629906
|
Steele BW et al. |
A longitudinal replicate study of immunosuppressive drugs: a College of American Pathologists study. |
2003 |
Arch. Pathol. Lab. Med. |
pmid:12653570
|
Wang S et al. |
A fast and simple high-performance liquid chromatography/mass spectrometry method for simultaneous measurement of whole blood tacrolimus and sirolimus. |
2005 |
Arch. Pathol. Lab. Med. |
pmid:15859639
|
Gorgan M et al. |
Pulmonary hemorrhage with capillaritis secondary to mycophenolate mofetil in a heart-transplant patient. |
2013 |
Arch. Pathol. Lab. Med. |
pmid:24168511
|
Papadea C and Lage JM |
Immunosuppressants testing in transplantation. |
2004 |
Arch. Pathol. Lab. Med. |
pmid:15578873
|
Linder MW and Elin RJ |
Implications of methodologic bias for therapeutic drug monitoring. |
1999 |
Arch. Pathol. Lab. Med. |
pmid:10506447
|
Deschler DG et al. |
Posttransplantation lymphoproliferative disorder in patients under primary tacrolimus (FK 506) immunosuppression. |
1995 |
Arch. Otolaryngol. Head Neck Surg. |
pmid:7544136
|
Moura Penteado LA et al. |
Evaluation of the effect of tacrolimus on periodontitis induced in rats. |
2017 |
Arch. Oral Biol. |
pmid:28399470
|
Gürkan A et al. |
Alpha 2 integrin gene (ITGA2) polymorphism in renal transplant recipients with and without drug induced gingival overgrowth. |
2014 |
Arch. Oral Biol. |
pmid:24581850
|
Gürkan A et al. |
Gingival crevicular fluid transforming growth factor-beta1 in cyclosporine and tacrolimus treated renal transplant patients without gingival overgrowth. |
2008 |
Arch. Oral Biol. |
pmid:18342291
|
Guimarães MR et al. |
Protective effects of Tacrolimus, a calcineurin inhibitor, in experimental periodontitis in rats. |
2007 |
Arch. Oral Biol. |
pmid:17367747
|
Cota LO et al. |
Gingival overgrowth in cyclosporine, tacrolimus, or sirolimus-based immunosuppressive regimens and the single nucleotide IL-6 (-174 G/C) gene polymorphism. |
2010 |
Arch. Oral Biol. |
pmid:20430366
|
Emingil G et al. |
GCF and serum myeloperoxidase and matrix metalloproteinase-13 levels in renal transplant patients. |
2010 |
Arch. Oral Biol. |
pmid:20637451
|
Türkoğlu O et al. |
Are antimicrobial peptides related to cyclosporine A-induced gingival overgrowth? |
2015 |
Arch. Oral Biol. |
pmid:25555253
|
Liang L et al. |
Long-term outcomes of keratolimbal allograft for total limbal stem cell deficiency using combined immunosuppressive agents and correction of ocular surface deficits. |
2009 |
Arch. Ophthalmol. |
pmid:19901207
|
Murphy CC et al. |
Cyclosporine vs tacrolimus therapy for posterior and intermediate uveitis. |
2005 |
Arch. Ophthalmol. |
pmid:15883282
|
Okada AA |
Noninfectious uveitis: a scarcity of randomized clinical trials. |
2005 |
Arch. Ophthalmol. |
pmid:15883289
|
John SS et al. |
Chronic localized fibrosing vasculitis of the eyelid. |
2009 |
Arch. Ophthalmol. |
pmid:19822864
|
Orange D et al. |
Cellular immune suppression in paraneoplastic neurologic syndromes targeting intracellular antigens. |
2012 |
Arch. Neurol. |
pmid:22566506
|
Parashos SA et al. |
Determinants of the timing of symptomatic treatment in early Parkinson disease: The National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) Experience. |
2009 |
Arch. Neurol. |
pmid:19597081
|
Horne SM and Young KD |
Escherichia coli and other species of the Enterobacteriaceae encode a protein similar to the family of Mip-like FK506-binding proteins. |
1995 |
Arch. Microbiol. |
pmid:7540828
|
GarcÃa-Roca P et al. |
CYP3A5 polymorphism in Mexican renal transplant recipients and its association with tacrolimus dosing. |
2012 |
Arch. Med. Res. |
pmid:22704849
|
Saner FH et al. |
Severe neurological events following liver transplantation. |
2007 |
Arch. Med. Res. |
pmid:17174727
|
Lenz O and Contreras G |
Treatment options for severe lupus nephritis. |
2004 Sep-Oct |
Arch. Immunol. Ther. Exp. (Warsz.) |
pmid:15507877
|
Nowaczyk M et al. |
2-Chlorodeoxyadenosine: lack of synergism with cyclosporine A and tacrolimus (FK 506). |
1995 |
Arch. Immunol. Ther. Exp. (Warsz.) |
pmid:8744655
|
Campo JV et al. |
Tacrolimus toxic reaction associated with the use of nefazodone: paroxetine as an alternative agent. |
1998 |
Arch. Gen. Psychiatry |
pmid:9819077
|
Deckers-Kocken JM and Pasmans SG |
Successful tacrolimus (FK506) therapy in a child with pyoderma gangrenosum. |
2005 |
Arch. Dis. Child. |
pmid:15851442
|
Hofman T et al. |
Tacrolimus ointment does not affect the immediate response to vaccination, the generation of immune memory, or humoral and cell-mediated immunity in children. |
2006 |
Arch. Dis. Child. |
pmid:16798785
|